Literature DB >> 9693272

Neopterin-induced tumor necrosis factor-alpha synthesis in vascular smooth muscle cells in vitro.

G Hoffmann1, S Frede, S Kenn, M Smolny, H Wachter, D Fuchs, J Grote, J Rieder, W Schobersberger.   

Abstract

Synthesis and secretion of proinflammatory mediators like tumor necrosis factor-alpha and neopterin are common events in severe systemic inflammatory disorders, e.g. sepsis and septic shock. Recent data suggest that both substances show similarities with respect to their bioactivities. In the present study we investigated the potential interactions of neopterin and tumor necrosis factor-alpha on inducible nitric oxide synthase gene expression and nitric oxide generation in rat vascular smooth muscle cells. In addition, we studied the influence of neopterin on tumor necrosis factor-alpha synthesis in this cell type. Single stimulation of smooth muscle cells with either neopterin or tumor necrosis factor-alpha caused inducible nitric oxide synthase gene expression and nitric oxide production. Coincubation of cells with both compounds resulted in at least additive effects on nitric oxide synthesis. Quantification of tumor necrosis factor-alpha cDNA revealed a dose-dependent effect of neopterin on tumor necrosis factor-alpha gene expression. Similar results were obtained concerning the detection of tumor necrosis factor-alpha protein and the assessment of tumor necrosis factor-alpha bioactivity. These data suggest that neopterin and tumor necrosis factor-alpha are closely associated with regard to synthesis and effects, respectively. The interactions of both inflammatory mediators in vascular smooth muscle cells might contribute to the excessive release of nitric oxide observed during sepsis, thus triggering cellular destruction and multiple organ failure.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9693272     DOI: 10.1159/000023950

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  6 in total

1.  Modulation of neopterin formation and tryptophan degradation by Th1- and Th2-derived cytokines in human monocytic cells.

Authors:  G Weiss; C Murr; H Zoller; M Haun; B Widner; C Ludescher; D Fuchs
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

2.  Gamma interferon is dispensable for neopterin production in vivo.

Authors:  R Sghiri; J Feinberg; F Thabet; K Dellagi; J Boukadida; A Ben Abdelaziz; J L Casanova; M R Barbouche
Journal:  Clin Diagn Lab Immunol       Date:  2005-12

3.  CSF neopterin level as a diagnostic marker in primary central nervous system lymphoma.

Authors:  Aurélien Viaccoz; François Ducray; Yannick Tholance; Gleicy Keli Barcelos; Laure Thomas-Maisonneuve; Hervé Ghesquières; David Meyronet; Isabelle Quadrio; Stéphanie Cartalat-Carel; Guy Louis-Tisserand; Emmanuel Jouanneau; Jacques Guyotat; Jérôme Honnorat; Armand Perret-Liaudet
Journal:  Neuro Oncol       Date:  2015-05-25       Impact factor: 12.300

4.  Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection.

Authors:  Lars Hagberg; Paola Cinque; Magnus Gisslen; Bruce J Brew; Serena Spudich; Arabella Bestetti; Richard W Price; Dietmar Fuchs
Journal:  AIDS Res Ther       Date:  2010-06-03       Impact factor: 2.250

5.  Neopterin inhibits ATP-induced calcium release in alveolar epithelial cells in vitro.

Authors:  Georg Hoffmann; Frank Gollnick; Rainer Meyer
Journal:  Mediators Inflamm       Date:  2002-06       Impact factor: 4.711

6.  Associations Between Plasma Immunomodulatory and Inflammatory Mediators With VACS Index Scores Among Older HIV-Infected Adults on Antiretroviral Therapy.

Authors:  Thomas A Premeaux; Shireen Javandel; Kalei R J Hosaka; Meredith Greene; Nicholas Therrien; Isabel E Allen; Michael J Corley; Victor G Valcour; Lishomwa C Ndhlovu
Journal:  Front Immunol       Date:  2020-06-30       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.